If you're one of the 65 million Americans said to rely on this drug, you'll want to see if your prescription's been impacted.

Blood pressure medication recall: What you need to know. The FDA continues to update the list of medications being recalled. By Dr. Tulsie N. Patel and Dr. Sumir Shah. September 24, 2019, 5:52 PM.

So if you are taking another blood pressure medication or a medication that ends in "-sartan" from another manufacturer that is not listed on the FDA recall announcements, you should not be ...

A pharmaceutical company is recalling a blood pressure medication due to a potential cancer risk, the FDA announced this week. Aurobindo Pharma USA is recalling two lots of quinapril and ...

Granules India is recalling more than 33,000 bottles of a generic blood pressure lowering medication from US shelves due to ...

Indian drugmaker Granules has issued a voluntary recall of more than 33,000 bottles of the generic high blood pressure treatment metoprolol succinate, citing the drug's failure to meet dissolution ...

Two lots of Aurobindo's 20 mg/12.5 mg are included in the recall, both with expiration dates through January 2023, and the specific lot numbers can be found in the recall announcement on Oct. 25.

A second pharmaceutical company has recalled a blood pressure medication that could increase the risk of cancer if taken in large amounts, the U.S. Food and Drug Administration announced last week ...

NRA-Amlodipine 5 mg, DIN 02476460. Issue: Health products - Product safety. What to do: Check your bottle of NRA-Amlodipine 5 mg ...

Health Canada issued a public advisory after a drug used to treat high blood pressure and chest pain has been recalled ...

The Hyderabad-based drug maker is recalling 33,024 bottles of Metoprolol Succinate extended-release tablets in 100 count and ...

Granules India recalls 33,000 bottles of Metoprolol Succinate due to manufacturing issues. The US FDA initiated a Class II recall.